Crowdonomics
216 Pharmacy Corp

Reg A+ · Equity · Sep 2025

OpenReg A+Equity
via the platform · last checked Sep 25, 2026
Raised
$0 / $15M max
0% of ceiling
Investors
—
—
Momentum
$0/day
—

Financials disclosed in this offering

FY2024 · hover for source
$0
−$57K
FY2024
RevenueNet income
Metric
FY2024 unaudited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$57,237
Balance sheet
Cash
$3,975
Accounts receivable
$10,283
Total assets
$14,258
Long-term debt
$0
Total liabilities
$22,895
Other
Headcount
0

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Aug 29, 2025
    Amended during SEC review — offering terms unchanged
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$45M
Price / share$1.50
Shares offered10,000,000

Estimated, not stated: $1.50 × 30,000,000 securities outstanding as of Aug 29, 2025 (Form 1-A/A filed Aug 29, 2025).

Offering details

Target—
Max$15,000,000
Min investment—
OpenedSep 4, 2025
Deadline—
Days active401

Links & provenance

Source: SEC EDGAR
0001096906-25-001425
Last synced Sep 25, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.